An interleukin 3-dependent multipotential stem cell clone, LyD9, has been shown to generate mature B lymphocytes, macrophages, and neutrophils by coculture with primary bone marrow stromal cells. We report here that coculture with the cloned stromal cell lines PA6 and ST2 can support differentiation of LyD9 cells predominantly into granulocyte/macrophage colonystimulating factor (GM-CSF)-and granulocyte (G)-CSF-responsive cells, respectively. However, these stromal cell lines were unable to support lymphopoiesis of LyD9 cells. The GM-CSF-dependent line, L-GM, which was derived from LyD9 cells cocultured with PA6 stromal cells, could differentiate into macrophages and granulocytes in the presence of GM-CSF. The LGM line can further differentiate predominantly into neutrophils by coculture with ST2 stromal cells. The G-CSFdependent line, LG, which was derived from LyD9 cells cocultured with ST2 stromal cells, differentiated into neutrophils in response to G-CSF. Although the stromal cell-supported differentiation of LyD9 cells required the direct contact between LyD9 and stromal cells, a small fraction of LyD9 cells that were pretreated with 5-azacytidine could differentiate into neutrophils and macrophages without direct contact with stromal cells. These results indicate that different stromal cell lines support lineage-selective differentiation of the LyD9 stem cell and that 5-azacytidine treatment can bypass the requirement of direct contact with stromal cells, albeit with a lower frequency.
T he totipotent bone marrow stem cell is defined as a cell that has the potential to reproduce itself as well as to give rise to cells of each lineage in the blood . During the course of differentiation, progeny of the totipotent stem cell gradually lose their`capacity to differentiate into particular lineages, giving rise to multipotent stem cells that eventually become committed to a single cell lineage. Stem cells proliferate, differentiate, and mature in the presence of growth factors . The totipotent bone marrow stem cell has been difficult to maintain in vitro because a growth factor for the totipotent stem cell has not been isolated. On the other hand, molecular cloning of cDNAs encoding growth factors and lymphokines, and their large-scale production, have facilitated establishment of multipotent stem cell lines and progenitor cell lines cultured in vitro (1) (2) (3) . IL3 has been shown to support the growth of multipotent stem cells without induction of differentiation (4, 5) . Several progenitor cell lines such as FDCP-mix A4 and 32D C13 can be induced to a specific lineage by a lineage-specific growth factor, although they generally proliferate and remain undifferentiated in media containing IL-3 (6, 7) .
Another regulatory element of hematopoiesis is a stromal cell network in the bone marrow. This idea is supported by the finding that bone marrow stromal cells are a necessary requirement for a long-term bone marrow culture system, in which hemopoiesis of various cell lineages can be sustained without added growth factors (8, 9) . Interestingly, the hemopoietic cells must be in direct contact with the stromal cells for proliferation and differentiation (10) . Recently, stromal cell lines such as PA6 and ST2 (11) (12) (13) were shown to support differentiation of primary bone marrow cells into distinct lineage cells (14) . Such functional diversity of stromal cells could be ascribed to different growth factors produced or differential cell adhesion molecules expressed by each stromal cell . Combination of appropriate growth factors derived from stromal cells and growth factor receptors expressed by progenitor cells might be a key element for the lineage-specific differentiation . In addition, an appropriate pair of cell adhe-sion molecules expressed on stromal and stem cells could be required for not only proliferation signal triggering but also specific growth factor/receptor expression .
The above experiments using primary bone marrow cells do not allow to distinguish (a) that a stromal cell line selectively expanded progenitors that were already committed and (b) that the stromal cell line supported differentiation of a multipotential stem cell in either stochastic or directive manner. It is therefore interesting to know whether different lineage cells differentiate from a single stem cell by coculture with different stromal cell lines. To address this question, we took advantage of an IL-3-dependent stem cell clone, LyD9 . This clone has been shown to differentiate into multiple lineage cells by coculture with bone marrow stromal cells: B lymphocytes, neutrophils, and macrophages (15) (16) (17) (18) . Differentiation of LyD9 cells requires direct contact with primary stromal cells (16) . We have found that two stromal cell lines, PA6 (11) and ST2 (13) , are able to support differentiation of the LyD9 stem cell line predominantly into two different lineage cells: granulocyte/macrophage-colony-stimulating factor (GM-CSF)t-responsive and granulocyte CSF (G-CSF)-responsive cells, respectively.
Materials and Methods
Cell Lines. The procedure for the establishment and detailed characterization of the LyD9 cell clone has been described (15) . It grows in RYMI 1640 supplemented with 10% (vol/vol) FCS, 50 fAM 2-ME, 2 MM r.-glutamine, and 5% WEHI 313-conditioned medium . The LyD9 cell line was recloned in our laboratory. The ST2-S10 (ST2) and MC3T3-G2/PA6 (PA6) cell lines were established from the bone marrow of NZB mice and the preadipose tissue of calvaria of newborn mice, respectively (11, 13) .
SAzacytidine Treatment ofLyD9 Cells. 5-Azacytidine treatment of LyD9 cells before coculture was carried out basically according to Castellazzi et al . (19) . 5-Azazrytidine was added to 5 jAg/ml in a 5-ml culture of LyD9 cells (106 cells/ml). The concentration of 5-azacytidine was diluted to half by the addition of an equal volume of fresh medium after 24 h of the culture. 2 d later, cells were washed to remove 5-azacytidine, cultured for 10 d, and used for induction.
Induction of Differentiation with Stromal Cell Lines. LyD9 cells (106) or 5-azacytidine-treated LyD9 cells (106) were cocultured on either ST2 or PA6 cells. To test the requirement of direct contact, cells were separated from stromal layers by a membrane chamber (pore size, 0.45 Am) (Millipore Continental Water Systems, Bedford, MA). The condition for coculture is the same as that for maintenance of LyD9 cells, except that WEHI 313-conditioned medium is reduced to 0.7% for the minimal maintenance of the LyD9 cells. After a 1-d coculture, floating cells were removed, and adhering cells were further cultured for the induction of differentiation . PA6 and ST2 stromal cell layers were changed several times during the coculture, and the culture supernatant (0 .7%) of WEHI 313 cells was supplied in coculture every third day. Every week thereafter, the cocultured LyD9 cells were harvested and washed, and then 106 cells were transferred to wells containing one of the following CSFs : GM-CSF (20 U/ml), macrophage CSF (M-CSF) (10% of I Abbreviation used in this paper: GM-CSF, granulocyte/macrophage colonystimulating factor.
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Stromal Cell Lines Support Differentiation of LyD9 the L cell culture supernatant), and G-CSF (100 U/ml). Viable cells were counted 10 d after the transfer to growth factor-containing medium.
Establishment ofthe
LGMLine. LyD9 cells were maintained on a monolayer of PA6 stromal cells in the presence of 0.7% of WEHI 313 culture supernatant. 4 wk later, cocultured LyD9 cells were transferred to media containing GM-CSF (20 U/ml). GM-CSFresponding cells were maintained for >2 mo, and their morphology, cytochemical staining, surface phenotypes, and responsiveness to the growth factors were characterized. The LGM line was maintained in media containing IL-3 .
Establishment ofthe LG Line. LyD9 cells pretreated with 5-azacytidine were cocultured on ST2 stromal cells as described above, and transferred after 4 wk to media containing G-CSF (100 U/ml). G-CSF-responding cells obtained were transferred to the medium containing a low concentration of 11,3 after we confirmed that cells became nonviable without G-CSF. Morphological and cytochemical analyses of LG cells were performed after culturing in G-CSF for 10 d. Characterization ofLyD9 Cells and their Derivatives. May-Griinwald-Giemsa staining was used for morphological study. Staining of a-naphthylbutyrate and naphthol AS-D chloroacetate esterase was done by a commercial kit (Muto Chemical Company, Tokyo, Japan) . To determine the phagocytic activity, LGM cells were stimulated with 100 ng/ml PM (Sigma Chemical, Co ., St . Louis, MO) for 3 h. Cells were washed with the culture medium, and incubated with latex beads (0 .8 p,m; Sigma Chemical Co.) for 6 h. After removal of the medium, cells were washed several times with the medium without FCS, stained with May-Grunwald-Giemsa, and observed by a phase contrast microscope (x 1000).
Growth Assay ofLGMand LG. Proliferative responses of LGM and LG cells to each growth factor were determined as described previously (17) . LGM and LG cells (4 x 10 4 cells/200 pl) were incubated in microtiter wells in the culture medium containing the growth factors indicated. The cultures in duplicate were incubated at 37°C . Cell proliferation was measured by [3H]thymidine uptake during the last 6 h of the 48 h incubation.
Growth Factors. Purified human rIL2 was provided by Takeda Pharmaceutical Company (Osaka, Japan) . 11,3 was obtained from culture supernatant of WEHI 313 cells. IL4 and 11,5 were obtained from X63Ag8 myeloma cells transferred with 11A and 11,5 cDNA, respectively (24) (25) (26) . Purified human rIL6 (27) was provided by Dr. T. Hirano (Osaka University) . Murine rGM-CSF (28) was provided by Dr. T Sutlo (Biomaterials Research Institute Co., Kanagawa, Japan) . Purified human rG-CSF (29) and human M-CSF were provided by Dr . S. Nagata (Osaka Bioscience Institute) . PA6 cells (106) were layered on a plate in the same medium as that for LyD9 cells, except for the absence of IL3. LPS (1 Fig/ml ; Sigma Chemical Co.) was added during last 3 d of the culture. The culture supernatant of PA6 cells was collected on day 5, and concentrated by a nitrocellulose membrane filter (0 .45 pm; YM10; Amicon Corp., Danvers, MA).
Results
Generation of Myeloid Cells from LyD9 Cells by Coculture with Stromal CellLines. Differentiation of LyD9 cells by coculture with the stromal cell line PA6 was investigated by morphological and cytochemical studies. A considerable proportion (ti0 .1%) of LyD9 cells cocultured with PA6 cells for 4 wk contained myeloid-like nuclei and became positive for myeloid-specific enzymes such as a-naphthylbutyrate esterase and myeloperoxidase (Fig. 1) . The proportion of myeloid cells increased when LyD9 cells were pretreated with 5-azacytidine. Similar experiments using ST2 stromal cells did not yield a detectable number of myeloid cells . However, 5-azacytidinetreated LyD9 cells cocultured with ST2 cells produced a considerable portion (N0.1%) of myeloid cells (data not shown) .
To characterize differentiated cells, an aliquot (106 cells) of LyD9 cells cocultured with the stromal cell line (either PA6 or ST2) was transferred every week to media containing either GM-CSF, G-CSF, or M-CSF. Viable cells were scored 10 d after the transfer to growth factor-containing media. As shown in Table 1 , 4-wk coculture of LyD9 cells with PA6 cells generated a significant number of GM-CSF-responding cells and a small number of G-CSF-responding cells. Pretreatment of LyD9 cells with 5-azacytidine enhanced and accelerated the induction of LyD9 cells into the myeloid cells by PA6 stromal cells. By contrast, when PA6 cells were replaced by ST2 cells, no GM-CSF-responding cells were generated, whereas a small number of G-CSF-responding cells were produced (Table 1) . 5-Azarytidine-treated LyD9 cells differentiated into G-CSF-responding cells more quickly and more efficiently by coculture with ST2 cells . Similar experiments with PA6 or ST2 cells did not give rise to M-CSF-responsive cells even after 4 wk of coculture.
Establishment of GM-CSF-and G-CSF-dependent Cell Lines from LyD9 Cells. LyD9 cells that had been cocultured with PA6 stromal cells were cultured in media containing GM-CSF for >4 wk, and thereafter, grown cells were maintained as a cell line called DGM . Similarly, the IrG line was generated from 5-azacytidine-treated LyD9 cells by coculture with the ST2 stromal line, followed by subsequent selection in G-CSF-containing medium . IrGM and IrG cells grew in the presence of GM-CSF and G-CSF, respectively (Fig. 2) . However, the growth response of IrG cells to G-CSF was tran- 
Cytochemical studies were performed to characterize the differentiation properties of the ITGM and ITG lines cultured in GM-CSF and G-CSF, respectively (Fig. 3) . About onethird of the DGM cells that had been cultured in the presence of GM-CSF had bent nuclei with a small nuclealcytoplasmic ratio (Fig. 3 a) .
LGM cells also were positive for ci-naphthylbutyrate esterase and myeloperoxidase (Fig. 3,  b and c) . Only a few neutrophils (<0 .01%) were found in ITGM cells . LGM cells showed phagocytic activity when stimulated with PMA (Fig. 3 d ) . A few percent of the DGM cells appeared as mature macrophages even when cultured in IIT3 for 1 mo. By contrast, the majority of ITG cells that had been cultured for 10 d in the presence of G-CSF became neutrophils with typical lobulated nuclei and naphthol AS-D chloroacetate esterase-positive granules (Fig. 3, e and f) .
The surface phenotype of ITGM cells was consistent with that of myeloid lineage cells . As shown in Fig. 4, LGM cells expressed more Mac 1, F4/80, and la antigens than LyD9 cells . Expression of the B220 and Fc-y receptor antigens on ITGM was as high as that on LyD9 cells. LGM cells did not express IgM. Surface antigens of the ITG line could not be studied because of the strong auto-fluorescence of this line.
LGM Cells Can Differentiate into Neutrophils. When ITGM cells were further cocultured with ST2 cells in the presence of 25 Ag/ml LPS for 1 mo, -30% of the cocultured ITGM cells had the morphological and cytochemical properties of neutrophils (Fig. 5) . Similar experiments with another GM-CSF-dependent derivative of LyD9, K-GM (17), yielded similar results (data not shown) . Since monocyte/macrophage lineage cells appeared in LGM and K-GM cells that had been cultured with GM-CSF, these results indicate that both ITGM Table 1 and K-GM cell lines are progenitors of neutrophils and macrophages.
G-CSF Induces Diferentiation and Eventual Death of LG
Cells.
LG cells proliferated and differentiated into neutrophils in the presence of G-CSF, but gradually ceased to proliferate and the majority of them died within 2 wk. IrG cells grew almost indefinitely when cultured in medium containing 11,3. However, the morphological characteristics of neutrophils disappeared in the IL3 containing medium in 1 mo (Fig. 3 g) . Neutrophil characteristics such as lobular nuclei were regained by transferring L-G cells into G-CSF-containing medium (Fig . 3 h) . Experiments were done as described in Table 1 , except that LyD9 and stromal cells were cultured in separate membrane chambers (pore size, 0.45 pro) . GM-CSF-responding cells without direct contact (Table 2) . Much smaller but significant numbers of G-CSF-responding cells were also induced . Under the same conditions, ST2 stromal cells could support differentiation of G-CSF-responding cells but not of GM-CSF-responding cells. The 5-azacytidine treatment of LyD9 cells before the coculture allowed generation of GM-CSF-and G-CSF-responding cells without direct contact with stromal cells, but the lineage specificity of the stromal cells was not altered by this treatment . We then tested whether the culture supernatant of PA6 cells is able to induce differentiation of LyD9 cells into myeloid cells. As shown in Table 3 , 5-azarytidine-treated LyD9 cells were induced to differentiate into GM-CSF-dependent cells by preincubation with supernatant from PA6 cells . After screening with known growth factors, we found that GM-CSF itself could replace the supernatant of PA6 cells. Anti-GM-CSF antibody could inhibit proliferation of GM-CSF-responding cells from 5-azarytidine-treated LyD9 cells by the PA6 supernatant . GM-CSF mRNA was found in PA6 and ST2 cells by PCR (data not shown) . We estimated the frequency of GM-CSF-responding cells in 5-azarytidine-treated LyD9 cells by culturing these cells in methylcellulose . As shown in Table 4 , only two to six cells out of 106 5-azarytidine-treated LyD9 cells formed colonies in the presence of GM-CSF, whereas 55-80% of the LyD9 cells formed colonies in the presence of GM-CSF, whereas 55-80% of the LyD9 cells formed large colonies in the presence of 11,3. It is, therefore, likely that the 5-azarytidine treatment of LyD9 cells produced a small fraction of cells that could bypass at least a part ofthe function of PA6 stromal cells.
Discussion
We have established a well-defined in vitro system for myeloid differentiation from a multipotent stem cell clone . This system includes the stem cell clone LyD9 and the cloned stromal cell lines PA6 and ST2 . LyD9 cells cocultured with the PA6 and ST2 stromal cell lines differentiated predominantly into GM-CSF-and GCSF-responsive cells, respectively. In our previous system, using a primary culture of bone marrow stromal cells, direct contact with stromal cells was required for the proliferation and differentiation of LyD9 cells (16) . This conclusion was supported in the present system using stromal cell lines because the membrane chamber experiments practically abolished the generation of GM-CSFand G-CSF-responding cells (Table 2) . However, the present study has shown that the cell contact requirement is circumvented by 5-azacytidine treatment of LyD9 cells, though the numbers of GM-CSF-responding cells decreased considerably without the contact (Tables 2 and 3) . 5-Azacytidine treatment is known to activate several important genes involved in differentiation (30, 31) . Since 5-azacytidine treatment of LyD9 cells allowed generation of GM-CSF-responding cells, it is likely that stromal cell contact induces transcription of a set of genes that are activated by 5-azacytidine treatment . As the 5-azacytidine-treated LyD9 cells gave rise to GM-CSFresponsive cells, genes activated by this treatment may include those for (a) the GM-CSF receptor, (b) the cytoplasmic signal transduction pathway of the GM-CSF receptor, and (c) the regulatory proteins for target genes activated by GM-CSF. In fact GM-CSF receptor expression is required at least because the GM-CSF receptor was not expressed on the LyD9 cells by the binding assay (32) . Comparison of these two cells, i .e., LyD9 cells and GM-CSF-responsive derivatives, will provide important clues to understanding which genes need to be activated for the lineage commitment .
We previously reported the establishment of several different myeloid progenitor cells derived from the LyD9 cell (17) . The K-5 cell line proliferates without differentiation in the presence of either IL5 or IL3 (33) . K-5 cells differentiate into neutrophils and macrophages by coculture with PA6 stromal cells . K-GM and IrGM cells proliferate in the presence of either 11,3 or GM-CSF. Both cells can be induced to differentiate into neutrophils when cocultured with ST2 stromal cells. LS-1 cells grow in the presence of any of the four growth factors : IL3, GM-CSF, G-CSF, and M-CSF (17) . IrG cells grow in the presence of IL3 and differentiate in response to G-CSF. These derivatives can be classified into two groups : (a) those that differentiate by coculture with stromal cells (K-5, K-GM, and IrGM), and (b) those (LS-1 and ILG) that can be induced to differentiate by growth factors .
Transfer of several IIr3-dependent cell lines from IL3 to a different CSF results in the induction of terminal differentiation. FDCP-mix (4, 7), NFS-60 (34), and 32D C13 (6) cell lines respond to GM-CSF, erythropoietin, and G-CSF, respectively. All these lines are distinct from LyD9 but rather similar to its committed derivatives like LS-1, DGM, K-GM, and IrG cells because the above three lines are committed to either myeloid or erythroid lineages, whereas LyD9 cells are not committed to either the myeloid or the lymphoid lineage (17) . Coculture of LyD9 cells with PA6 and ST2 stromal cells will thus provide a useful system to dissect molecular mechanisms of commitment to the myeloid lineage.
